RxDoctor Payments Data

James Vestile, DPM

Podiatrist · Tipton, INNPI 1174881148

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $28,001 of the $43,699 with a category attached, or 64.1%. 31 manufacturers reported payments, led by Ortho Solutions Inc at 27.5% of the total. Reporting peaked in 2022 at $13,955 and has fallen 94.0% since, to $843 in 2025. Among podiatrist clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$43,699in general payments, 2019–2025

Across 120 payments — averaging $364.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ortho Solutions Inc$12K
  • Flower Orthopedics Coporation$12K
  • Ossio Inc$6K
  • Bioventus LLC$4K
  • New Standard Device, LLC Dba Metalogix$3K
  • Crossroads Orthopedics, LLC$1K
  • plus $5K from 25 others
$3,000in research payments, 2019–2025

Across 1 payment — averaging $3000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Skye Orthobiologics LLC$3K

What the payments were for

  • Consulting fees$28,00164%
  • Speaking & faculty fees$3,8889%
  • Travel & lodging$3,6478%
  • Food & beverage$5,96314%
  • Education$2,2005%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$43,699 in reported general payments places this provider in the 95th percentile of 131 podiatrist providers in Indiana.

See all podiatrist providers in Indiana

Medicare billing

Part B allowed, 2024
$519,429
Medicare patients
82
Services billed
1,485

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip30$838
Duloxetine Hcl49$651
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen109$644
Pregabalin19$386
Cephalexin49$340
Gabapentin43$321
Doxycycline Hyclate13$186
Methylprednisolone40$183
Ciprofloxacin Hcl13$110
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen11$88
Terbinafine Hcl12$79

Paid to pharmacies, not to this prescriber.

Other podiatrist in Tipton

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →